Serina Therapeutics, Inc.
About
Serina Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 2 2026
Serina Therapeutics Announces NYSE American Acceptance of Continued Listing Compliance Plan
Mar 25 2026
Serina Therapeutics Reports Full Year 2025 Financial Results and Recent Business Highlights
Mar 24 2026
Serina Therapeutics to Present at the 38th Annual Roth Conference
Mar 18 2026
Serina Therapeutics Secures up to $30 Million in Private Placement to Advance Registrational Trial of SER-252 for Advanced Parkinson’s Disease
Feb 24 2026
Serina Therapeutics Announces Dosing of First Patient in Phase 1b Registrational Trial of SER-252 for Advanced Parkinson’s Disease